In financial year 2023, in India, GSK Pharmaceuticals Limited spent approximately 79 million Indian rupees on the non-ongoing project related to the corporate social responsibility (CSR). Nearly 71 million Indian rupees was spent on donations of Albendazole, a medication used in the effort to eradicate Lymphatic Filariasis. In financial year 2023, GSK ranked as the leading brand in the anti-infectives and dermatology segment.
Corporate Social Responsibility expenditure of GSK Pharmaceuticals Limited other than ongoing projects in India during financial year 2023, by expense
(in million Indian rupees)
Characteristic
Expenditure in million Indian rupees
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
GlaxoSmithKline. (June 17, 2023). Corporate Social Responsibility expenditure of GSK Pharmaceuticals Limited other than ongoing projects in India during financial year 2023, by expense (in million Indian rupees) [Graph]. In Statista. Retrieved August 24, 2024, from https://www.statista.com/statistics/1249480/india-gsk-pharmaceuticals-additional-csr-expenditure/
GlaxoSmithKline. "Corporate Social Responsibility expenditure of GSK Pharmaceuticals Limited other than ongoing projects in India during financial year 2023, by expense (in million Indian rupees)." Chart. June 17, 2023. Statista. Accessed August 24, 2024. https://www.statista.com/statistics/1249480/india-gsk-pharmaceuticals-additional-csr-expenditure/
GlaxoSmithKline. (2023). Corporate Social Responsibility expenditure of GSK Pharmaceuticals Limited other than ongoing projects in India during financial year 2023, by expense (in million Indian rupees). Statista. Statista Inc.. Accessed: August 24, 2024. https://www.statista.com/statistics/1249480/india-gsk-pharmaceuticals-additional-csr-expenditure/
GlaxoSmithKline. "Corporate Social Responsibility Expenditure of Gsk Pharmaceuticals Limited Other than Ongoing Projects in India during Financial Year 2023, by Expense (in Million Indian Rupees)." Statista, Statista Inc., 17 Jun 2023, https://www.statista.com/statistics/1249480/india-gsk-pharmaceuticals-additional-csr-expenditure/
GlaxoSmithKline, Corporate Social Responsibility expenditure of GSK Pharmaceuticals Limited other than ongoing projects in India during financial year 2023, by expense (in million Indian rupees) Statista, https://www.statista.com/statistics/1249480/india-gsk-pharmaceuticals-additional-csr-expenditure/ (last visited August 24, 2024)
Corporate Social Responsibility expenditure of GSK Pharmaceuticals Limited other than ongoing projects in India during financial year 2023, by expense (in million Indian rupees) [Graph], GlaxoSmithKline, June 17, 2023. [Online]. Available: https://www.statista.com/statistics/1249480/india-gsk-pharmaceuticals-additional-csr-expenditure/